身体外心肺复苏的实际成本:基于时间驱动的基于活动的成本研究
Vinodh B Nanjayya1,2, Alisa M Higgins2, Laura Morphett3
1Intensive Care Department, Alfred Hospital, Melbourne, VIC, Australia.
Critical care explorations
|July 3, 2024
概括
身体外心肺复苏 (E-CPR) 是昂贵的,平均每周期75,014美元. 重症监护室和手术费用是主要的驱动因素,医院内心脏骤停病例更昂贵.
科学领域:
- 关键护理医学 关键护理医学
- 卫生经济学 卫生经济学
- 心血管外科心血管外科
背景情况:
- 身体外心肺复苏 (E-CPR) 是对耐心性心脏骤停的救生干预.
- 了解E-CPR的经济影响对于资源分配和未来的成本效益分析至关重要.
研究的目的:
- 确定E-CPR护理周期的实际成本和确定主要成本驱动因素.
- 为了比较与医院内心脏骤停 (IHCA) 与医院外心脏骤停 (OHCA) 相关的E-CPR成本.
主要方法:
- 从医疗保健提供者的角度进行了一项基于时间驱动的基于活动的成本研究.
- 为E-CPR护理周期制定了详细的过程图,从启动到出院或死亡.
- 收集和分析了临床和非临床资源利用和时间数据,以计算总直接和间接成本.
主要成果:
- 一个E-CPR护理周期的平均成本为75,014美元.
- 重症监护室 (ICU) 管理 (35%) 和手术费用 (20%) 是主要的成本决定因素.
- IHCA的电子CPR比OHCA (62,595美元) 昂贵得多 (87,940美元),主要是因为ICU停留时间更长,生存率更高.
结论:
- 对于耐心性心脏骤停的E-CPR造成了相当大的医疗保健费用.
- 集中治疗和手术费用是E-CPR整体成本的主要贡献者.
- 这些发现为未来对E-CPR干预措施的成本效益评估提供了重要的数据.
更多相关视频
06:10Author Spotlight: Assessment of Cardiac Output Calculation by Thermodilution in Pigs for Effective Perfusion Flow During EVLP
Published on: June 28, 2024
475
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
393
相关概念视频
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
Cardiopulmonary Resuscitation I: Adult
1.3K
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.3K
Cardiopulmonary Resuscitation III: AED Use
1.7K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
